Stocks · News reference
Filed: 2026-07-30 AccNo: 0000724004-26-000082 Size: 275 KB Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics Item 9.01: Financial Statements and Exhibits
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $94 to $110.
Read original at benzingaMesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.40 by 11.67 percent. This is a 15.52 percent increase over earnings of $2.32 per share from
Read original at benzingaMesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $0.03 by 8833.33 percent. This is a 15.52 percent increase over earnings of $2.32 per share
Read original at benzinga